Journal profile · Pathology
Diagnostic Pathology
ISSN 1746-1596 · BioMed Central · ENGLAND · Irregular · Founded 2006
Diagnostic Pathology: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.4; fully open access; APC about USD 3,090; median 123 days to acceptance (107 articles, last 24 months); community-reported acceptance: about 50%; 143 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Diagnostic Pathology is published by BioMed Central and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are AI in cancer detection, Sarcoma Diagnosis and Treatment and Lymphoma Diagnosis and Treatment, together about 23.7% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Diagnostic Pathology is an open access, peer-reviewed, online journal that considers research in surgical and clinical pathology, immunology, and biology, with a special focus on cutting-edge approaches in diagnostic pathology and tissue-based therapy. The journal covers all aspects of surgical pathology, including classic diagnostic pathology, prognosis-related diagnosis (tumor stages, prognosis markers, such as MIB-percentage, hormone receptors, etc.), and therapy-related findings. The journal also focuses on the technological aspects of pathology, including molecular biology techniques, morphometry aspects (stereology, DNA analysis, syntactic structure analysis), communication aspects (telecommunication, virtual microscopy, virtual pathology institutions, etc.), and electronic education and quality assurance (for example interactive publication, on-line references with automated updating, etc.).
From the journal's Aims & Scope
Research area (LetPub): Pathology
Editor-in-chief Anil V. ParwaniPublisher website
Editorial board by country: 2 in mainland China (about 2%); most named United States 53, Italy 9, India 7, Egypt 4, Germany 3 (104 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- AI in cancer detectionComputer Science8.8%
- Sarcoma Diagnosis and TreatmentMedicine8.4%
- Lymphoma Diagnosis and TreatmentMedicine6.5%
- Salivary Gland Tumors Diagnosis and TreatmentMedicine4.7%
- Breast Lesions and CarcinomasMedicine4.5%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.4%
- Vascular Tumors and AngiosarcomasMedicine4.3%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.4LetPub ·
- Impact factor (publisher) 2025
- 3.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 3Publisher website ·
- CiteScore 2026-06
- 4.4LetPub ·
- SJR 2026-06
- 0.88LetPub ·
- SNIP 2026-06
- 1.18LetPub ·
- h-index
- 44LetPub ·
- h-index
- 80OpenAlex ·
- i10-index
- 1,651OpenAlex ·
- 2-year mean citedness
- 3.85OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 137LetPub ·
- Downloads per year (publisher) 2025
- 2,000,000Publisher website ·
Articles by year OpenAlex count · 2,786 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 110 | 110 | 17 |
| 2025 | 143 | 143 | 340 |
| 2024 | 168 | 168 | 1,264 |
| 2023 | 134 | 134 | 1,410 |
| 2022 | 101 | 101 | 1,052 |
| 2021 | 119 | 119 | 2,242 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
123 daysMedian, submission to acceptance · P25–P75 71 days – 194 days
- Acceptance to online
- median 15 days (107 articles)
- Submission to online
- median 149 days
- Sample
- 107 articles with submission and acceptance dates (287 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 50%LetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,690 / USD 3,090 / GBP 2,290 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,990 / EUR 2,590 / GBP 2,190 | — | — | |
| LetPub | EUR 800 | Yes | — | |
| Publisher website | GBP 2,290 / USD 3,090 / EUR 2,690 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers2, by deadline
Publisher websiteArticle types accepted4
- brief reportResearch article Review Comment Brief reportLength not stated
- commentResearch article Review Comment Brief reportLength not stated
- research articleResearch article Review Comment Brief reportLength not stated
- reviewResearch article Review Comment Brief reportLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
Data sharing strongly encouraged or required; deposit in public repositories where appropriate. Model summary
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access under CC BY-NC-ND or CC BY licence; authors retain copyright. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Diagnostic Pathology articles are published open access under a CC BY-NC-ND (Creative Commons Attribution No…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Irregular
- Founded
- 2006
- ISSN
- 1746-1596
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Diagnostic Pathology
What CAS zone is Diagnostic Pathology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Diagnostic Pathology is in Zone 3 of Medicine, and in Zone 3 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Diagnostic Pathology?
The latest impact factor listed by LetPub is 3.4; CiteScore 4.4, h-index 80.
How long does peer review take at Diagnostic Pathology?
Based on the dates recorded on 107 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 123 days (interquartile range 71–194 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 50%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Diagnostic Pathology based?
Of the 104 board members whose country the journal's board page names, 2 (about 2%) are in mainland China; the countries named most often are United States (53), Italy (9) and India (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Diagnostic Pathology?
According to LetPub and DOAJ records, Diagnostic Pathology is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE and CAS; that list has not been checked against each database.
Is Diagnostic Pathology open access, and what is the APC?
Diagnostic Pathology is a fully open-access journal. APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .